Victory Capital Management
TNDM icon

Victory Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Victory Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Sell
10,469
-414
-4% -$7.23K ﹤0.01% 2294
2026
Q1 		$209K Buy
10,883
+1,112
+11% +$24.2K ﹤0.01% 2193
2025
Q4 		$215K Buy
+9,771
New +$176K ﹤0.01% 2187
2025
Q3 		– Sell
-12,160
Closed -$227K – 2547
2025
Q2 		$227K Sell
12,160
-85
-0.7% -$1.68K ﹤0.01% 2227
2025
Q1 		$235K Sell
12,245
-552,988
-98% -$16.2M ﹤0.01% 2188
2024
Q4 		$20.4M Sell
565,233
-22,014
-4% -$745K 0.02% 840
2024
Q3 		$24.9M Buy
587,247
+183,877
+46% +$7.8M 0.02% 772
2024
Q2 		$16.3M Buy
403,370
+389,632
+2,836% +$16.3M 0.02% 887
2024
Q1 		$486K Buy
13,738
+254
+2% +$6.8K ﹤0.01% 1990
2023
Q4 		$399K Sell
13,484
-85,256
-86% -$1.77M ﹤0.01% 2057
2023
Q3 		$2.05M Buy
98,740
+1,130
+1% +$31K ﹤0.01% 1387
2023
Q2 		$2.4M Buy
97,610
+6,407
+7% +$206K ﹤0.01% 1343
2023
Q1 		$3.7M Buy
91,203
+16,150
+22% +$669K ﹤0.01% 1261
2022
Q4 		$3.37M Buy
75,053
+9,573
+15% +$433K ﹤0.01% 1295
2022
Q3 		$3.13M Sell
65,480
-37,445
-36% -$2.05M ﹤0.01% 1348
2022
Q2 		$6.09M Sell
102,925
-110,964
-52% -$9.11M 0.01% 1203
2022
Q1 		$24.6M Sell
213,889
-43,372
-17% -$5.06M 0.02% 809
2021
Q4 		$38.7M Buy
257,261
+93,062
+57% +$12.6M 0.04% 653
2021
Q3 		$19.6M Buy
164,199
+28,941
+21% +$3.19M 0.02% 905
2021
Q2 		$13.2M Sell
135,258
-15,129
-10% -$1.35M 0.01% 1041
2021
Q1 		$13.3M Sell
150,387
-14,101
-9% -$1.31M 0.01% 1057
2020
Q4 		$15.7M Buy
164,488
+32,350
+24% +$3.33M 0.02% 973
2020
Q3 		$15M Buy
132,138
+119,923
+982% +$12.6M 0.02% 917
2020
Q2 		$1.21M Sell
12,215
-1,343
-10% -$107K ﹤0.01% 1639
2020
Q1 		$872K Sell
13,558
-131
-1% -$9.18K ﹤0.01% 1645
2019
Q4 		$816K Buy
13,689
+2,269
+20% +$140K ﹤0.01% 1799
2019
Q3 		$674K Buy
+11,420
New +$729K ﹤0.01% 1796

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Victory Capital Management's TNDM Position: Q2 2026 in Review

Victory Capital Management reduced its Tandem Diabetes Care (TNDM) stake by 3.8% in Q2 2026, selling an estimated $7.23K and leaving 10,469 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #2294.

Victory Capital Management first reported a position in TNDM in Q3 2019 and has held it in 27 quarters since. The position peaked at $38.7M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Victory Capital Management held 10,469 shares of Tandem Diabetes Care worth $158K as of Q2 2026.
  • Victory Capital Management sold 414 Tandem Diabetes Care shares in Q2 2026, an estimated $7.23K.
  • Tandem Diabetes Care made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2294 holding.
  • Victory Capital Management first reported a position in Tandem Diabetes Care in Q3 2019 and has held it in 27 quarters since.
  • Victory Capital Management's Tandem Diabetes Care position peaked at $38.7M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.